HRP20090632T1 - Novi derivati naftalena, postupak za njihovu pripravu i farmaceutski pripravci koji ih sadrže - Google Patents

Novi derivati naftalena, postupak za njihovu pripravu i farmaceutski pripravci koji ih sadrže Download PDF

Info

Publication number: HRP20090632T1
Authority: HR; Croatia
Prior art keywords: compound; formula; pharmaceutically acceptable; disorders; accordance
Prior art date: 2006-06-30

Application number

HR20090632T

Other languages

English (en)

Croatian (hr)

Inventor

Yous Said

Peres Basile

Sabaouni Ahmed

Berthelot Pascal

Spedding Michael

Delagrange Philippe

Caignard Daniel-Henri

Millan Mark

Original Assignee

Les Laboratoires Servier

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-06-30

Filing date

2009-11-27

Publication date

2010-01-31

2009-11-27 Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier

2010-01-31 Publication of HRP20090632T1 publication Critical patent/HRP20090632T1/hr

Links

238000000034 method Methods 0.000 title claims 2
150000002790 naphthalenes Chemical class 0.000 title 1
239000008194 pharmaceutical composition Substances 0.000 title 1
150000001875 compounds Chemical class 0.000 claims abstract 13
150000003839 salts Chemical class 0.000 claims abstract 6
HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims abstract 3
HEPRAZQZDVDTHU-UHFFFAOYSA-N N-[3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide Chemical compound C1=C(OC)C=C2C(C(CO)CNC(=O)CC)=CC=CC2=C1 HEPRAZQZDVDTHU-UHFFFAOYSA-N 0.000 claims abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
208000035475 disorder Diseases 0.000 claims 4
239000000825 pharmaceutical preparation Substances 0.000 claims 3
208000024827 Alzheimer disease Diseases 0.000 claims 2
208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 claims 2
239000003814 drug Substances 0.000 claims 2
229940079593 drug Drugs 0.000 claims 2
206010022437 insomnia Diseases 0.000 claims 2
238000004519 manufacturing process Methods 0.000 claims 2
230000007170 pathology Effects 0.000 claims 2
238000000926 separation method Methods 0.000 claims 2
208000000044 Amnesia Diseases 0.000 claims 1
208000019901 Anxiety disease Diseases 0.000 claims 1
208000020401 Depressive disease Diseases 0.000 claims 1
208000026139 Memory disease Diseases 0.000 claims 1
208000019695 Migraine disease Diseases 0.000 claims 1
HEPRAZQZDVDTHU-ZDUSSCGKSA-N N-[(2S)-3-hydroxy-2-(7-methoxy-1-naphthyl)propyl]propionamide Chemical compound C1=C(OC)C=C2C([C@H](CO)CNC(=O)CC)=CC=CC2=C1 HEPRAZQZDVDTHU-ZDUSSCGKSA-N 0.000 claims 1
206010028980 Neoplasm Diseases 0.000 claims 1
208000008589 Obesity Diseases 0.000 claims 1
206010033664 Panic attack Diseases 0.000 claims 1
208000018737 Parkinson disease Diseases 0.000 claims 1
208000028017 Psychotic disease Diseases 0.000 claims 1
206010039966 Senile dementia Diseases 0.000 claims 1
201000001880 Sexual dysfunction Diseases 0.000 claims 1
230000032683 aging Effects 0.000 claims 1
230000036506 anxiety Effects 0.000 claims 1
201000011510 cancer Diseases 0.000 claims 1
230000002490 cerebral effect Effects 0.000 claims 1
206010012601 diabetes mellitus Diseases 0.000 claims 1
210000002249 digestive system Anatomy 0.000 claims 1
IEJIGPNLZYLLBP-UHFFFAOYSA-N dimethyl carbonate Chemical compound COC(=O)OC IEJIGPNLZYLLBP-UHFFFAOYSA-N 0.000 claims 1
ATUOYWHBWRKTHZ-UHFFFAOYSA-N dimethylmethane Natural products CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 claims 1
230000002526 effect on cardiovascular system Effects 0.000 claims 1
206010015037 epilepsy Diseases 0.000 claims 1
230000010006 flight Effects 0.000 claims 1
150000004678 hydrides Chemical class 0.000 claims 1
239000002955 immunomodulating agent Substances 0.000 claims 1
229940121354 immunomodulator Drugs 0.000 claims 1
208000024714 major depressive disease Diseases 0.000 claims 1
201000003995 melancholia Diseases 0.000 claims 1
230000006984 memory degeneration Effects 0.000 claims 1
208000023060 memory loss Diseases 0.000 claims 1
206010027599 migraine Diseases 0.000 claims 1
235000020824 obesity Nutrition 0.000 claims 1
230000016087 ovulation Effects 0.000 claims 1
208000019906 panic disease Diseases 0.000 claims 1
230000001575 pathological effect Effects 0.000 claims 1
239000000546 pharmaceutical excipient Substances 0.000 claims 1
238000002360 preparation method Methods 0.000 claims 1
239000001294 propane Substances 0.000 claims 1
-1 propane amide Chemical class 0.000 claims 1
RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 claims 1
125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
201000000980 schizophrenia Diseases 0.000 claims 1
208000012672 seasonal affective disease Diseases 0.000 claims 1
231100000872 sexual dysfunction Toxicity 0.000 claims 1
208000019116 sleep disease Diseases 0.000 claims 1
230000035882 stress Effects 0.000 claims 1
239000000126 substance Substances 0.000 claims 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
- C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/02—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
- C07C233/04—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having nitrogen atoms of carboxamide groups bound to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals with carbon atoms of carboxamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pain & Pain Management (AREA)
Reproductive Health (AREA)
Immunology (AREA)
Gynecology & Obstetrics (AREA)
Obesity (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Psychology (AREA)
Emergency Medicine (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Anesthesiology (AREA)
Vascular Medicine (AREA)
Child & Adolescent Psychology (AREA)
Epidemiology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

HR20090632T 2006-06-30 2009-11-27 Novi derivati naftalena, postupak za njihovu pripravu i farmaceutski pripravci koji ih sadrže HRP20090632T1 (hr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0605917A FR2903102B1 (fr)	2006-06-30	2006-06-30	Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number	Publication Date
HRP20090632T1 true HRP20090632T1 (hr)	2010-01-31

Family

ID=37906940

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HR20090632T HRP20090632T1 (hr)	2006-06-30	2009-11-27	Novi derivati naftalena, postupak za njihovu pripravu i farmaceutski pripravci koji ih sadrže

Country Status (32)

Country	Link
US (1)	US7462741B2 (sr)
EP (1)	EP1873140B1 (sr)
JP (1)	JP4675938B2 (sr)
KR (1)	KR100912163B1 (sr)
CN (1)	CN101096346B (sr)
AR (1)	AR061740A1 (sr)
AT (1)	ATE444278T1 (sr)
AU (1)	AU2007203044A1 (sr)
BR (1)	BRPI0702817A (sr)
CA (1)	CA2593621C (sr)
CY (1)	CY1109663T1 (sr)
DE (1)	DE602007002591D1 (sr)
DK (1)	DK1873140T3 (sr)
EA (1)	EA012283B1 (sr)
ES (1)	ES2334278T3 (sr)
FR (1)	FR2903102B1 (sr)
GE (1)	GEP20094745B (sr)
HR (1)	HRP20090632T1 (sr)
MA (1)	MA29223B1 (sr)
MX (1)	MX2007007899A (sr)
MY (1)	MY142817A (sr)
NO (1)	NO20073295L (sr)
NZ (1)	NZ556188A (sr)
PL (1)	PL1873140T3 (sr)
PT (1)	PT1873140E (sr)
RS (1)	RS51079B (sr)
SG (1)	SG138589A1 (sr)
SI (1)	SI1873140T1 (sr)
TW (1)	TWI326679B (sr)
UA (1)	UA93190C2 (sr)
WO (1)	WO2008000968A1 (sr)
ZA (1)	ZA200704955B (sr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2903101B1 (fr) *	2006-06-30	2008-09-26	Servier Lab	Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2014056421A1 (zh) *	2012-10-09	2014-04-17	江西同和药业有限责任公司	1-氰基-1-（7-甲氧基-1-萘基）甲醇酯类化合物及其制备方法和应用
CN102875415B (zh) *	2012-10-09	2014-08-20	江西同和药业有限责任公司	一种化合物及其制备方法和应用
CN102875408B (zh) *	2012-10-09	2014-07-16	江西同和药业有限责任公司	一种阿戈美拉汀的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2689124A1 (fr) *	1992-03-27	1993-10-01	Adir	Nouvelles naphtylalkylamines, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
FR2737725B1 (fr) *	1995-08-08	1997-10-31	Valentonine	Nouveaux derives acyles de la melatonine et d'analogues melatoninergiques, leur procede de preparation et leur utilisation en tant que medicament
FR2771739B1 (fr) *	1997-11-28	2001-04-20	Adir	Nouveaux composes naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2784375B1 (fr) *	1998-10-12	2000-11-24	Adir	Nouveaux derives cycliques a chaine cycloalkylenique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2903101B1 (fr) *	2006-06-30	2008-09-26	Servier Lab	Nouveaux derives naphtaleniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

2006
- 2006-06-30 FR FR0605917A patent/FR2903102B1/fr not_active Expired - Fee Related
2007
- 2007-06-14 MY MYPI20070960A patent/MY142817A/en unknown
- 2007-06-18 MA MA30015A patent/MA29223B1/fr unknown
- 2007-06-26 ZA ZA200704955A patent/ZA200704955B/xx unknown
- 2007-06-26 SG SG200704785-5A patent/SG138589A1/en unknown
- 2007-06-27 UA UAA200707268A patent/UA93190C2/ru unknown
- 2007-06-27 MX MX2007007899A patent/MX2007007899A/es active IP Right Grant
- 2007-06-28 NZ NZ556188A patent/NZ556188A/en not_active IP Right Cessation
- 2007-06-28 NO NO20073295A patent/NO20073295L/no not_active Application Discontinuation
- 2007-06-28 US US11/823,771 patent/US7462741B2/en not_active Expired - Fee Related
- 2007-06-28 KR KR1020070064103A patent/KR100912163B1/ko not_active Expired - Fee Related
- 2007-06-29 PL PL07290819T patent/PL1873140T3/pl unknown
- 2007-06-29 CA CA2593621A patent/CA2593621C/fr not_active Expired - Fee Related
- 2007-06-29 EA EA200701178A patent/EA012283B1/ru not_active IP Right Cessation
- 2007-06-29 SI SI200730089T patent/SI1873140T1/sl unknown
- 2007-06-29 PT PT07290819T patent/PT1873140E/pt unknown
- 2007-06-29 AU AU2007203044A patent/AU2007203044A1/en not_active Abandoned
- 2007-06-29 GE GEAP200710154A patent/GEP20094745B/en unknown
- 2007-06-29 ES ES07290819T patent/ES2334278T3/es active Active
- 2007-06-29 DE DE602007002591T patent/DE602007002591D1/de active Active
- 2007-06-29 TW TW096123645A patent/TWI326679B/zh not_active IP Right Cessation
- 2007-06-29 WO PCT/FR2007/001105 patent/WO2008000968A1/fr not_active Ceased
- 2007-06-29 JP JP2007171622A patent/JP4675938B2/ja not_active Expired - Fee Related
- 2007-06-29 BR BRPI0702817-2A patent/BRPI0702817A/pt not_active IP Right Cessation
- 2007-06-29 AR ARP070102912A patent/AR061740A1/es unknown
- 2007-06-29 AT AT07290819T patent/ATE444278T1/de active
- 2007-06-29 EP EP07290819A patent/EP1873140B1/fr active Active
- 2007-06-29 CN CN2007101362902A patent/CN101096346B/zh not_active Expired - Fee Related
- 2007-06-29 RS RSP-2009/0502A patent/RS51079B/sr unknown
- 2007-06-29 DK DK07290819T patent/DK1873140T3/da active
2009
- 2009-11-27 HR HR20090632T patent/HRP20090632T1/hr unknown
- 2009-12-16 CY CY20091101309T patent/CY1109663T1/el unknown

Also Published As

Publication number	Publication date
PT1873140E (pt)	2009-10-21
ATE444278T1 (de)	2009-10-15
MY142817A (en)	2011-01-14
BRPI0702817A (pt)	2008-02-19
TW200811085A (en)	2008-03-01
CN101096346B (zh)	2010-12-15
TWI326679B (en)	2010-07-01
DK1873140T3 (da)	2010-01-11
UA93190C2 (ru)	2011-01-25
FR2903102B1 (fr)	2010-08-13
SI1873140T1 (sl)	2009-12-31
CA2593621A1 (fr)	2007-12-30
HK1111403A1 (en)	2008-08-08
ZA200704955B (en)	2008-08-27
MA29223B1 (fr)	2008-02-01
NO20073295L (no)	2008-01-02
EA200701178A1 (ru)	2008-02-28
NZ556188A (en)	2008-11-28
EP1873140B1 (fr)	2009-09-30
SG138589A1 (en)	2008-01-28
PL1873140T3 (pl)	2010-01-29
MX2007007899A (es)	2009-02-16
CN101096346A (zh)	2008-01-02
KR20080003265A (ko)	2008-01-07
JP2008013557A (ja)	2008-01-24
US20080004349A1 (en)	2008-01-03
DE602007002591D1 (de)	2009-11-12
US7462741B2 (en)	2008-12-09
WO2008000968A1 (fr)	2008-01-03
AU2007203044A1 (en)	2008-01-17
EA012283B1 (ru)	2009-08-28
GEP20094745B (en)	2009-07-27
FR2903102A1 (fr)	2008-01-04
ES2334278T3 (es)	2010-03-08
CY1109663T1 (el)	2014-08-13
RS51079B (sr)	2010-10-31
CA2593621C (fr)	2010-08-24
JP4675938B2 (ja)	2011-04-27
KR100912163B1 (ko)	2009-08-14
AR061740A1 (es)	2008-09-17
EP1873140A1 (fr)	2008-01-02

Publication	Publication Date	Title
HRP20170095T1 (hr)	2017-03-24	Novi kristalni oblik iii agomelatina, postupak za njegovu pripravu i farmaceutski pripravci istog
HRP20161672T1 (hr)	2017-02-10	Novi kristalni oblik vi agomelatina, postupak priprave i farmaceutski pripravci istog
JP6023727B2 (ja)	2016-11-09	高純度を有する２−［４−（３−または２−フルオロベンジルオキシ）ベンジルアミノ］プロパンアミドの製造方法
ME02574B (me)	2017-06-20	Novi sukristali agomelatina
ME02024B (me)	2015-05-20	Makrociklična jedinjenja hinoksalina kao inhibitori hcv ns3 proteaze
AU2006203340B2 (en)	2012-07-19	New crystalline form IV of agomelatine, a process for its preparation and pharmaceutical compositions containing it
US5552418A (en)	1996-09-03	Trisubstituted Naphthylalkylamides
KR20110025734A (ko)	2011-03-11	중추신경계 질환 및 질병 치료에 유효한 신규 화합물
JPH09510188A (ja)	1997-10-14	１−アミノインダン及びこれらの組成物
NO336967B1 (no)	2015-12-07	Ny krystallinsk form v av agomelatin, fremgangsmåte for dens fremstilling og farmasøytiske sammensetninger inneholdende den
AU2010234518A1 (en)	2012-02-02	Inhibitors of cognitive decline
US9212155B2 (en)	2015-12-15	Compounds advantageous in the treatment of central nervous system diseases and disorders
US9499462B2 (en)	2016-11-22	Isolated compounds from turmeric oil and methods of use
HRP20040250A2 (en)	2005-02-28	Crystals of hydroxynorephedrine derivative
CN104557588A (zh)	2015-04-29	咖啡酸和阿魏酸的同二聚体,其制备方法及其药物组合物
JP2021073171A (ja)	2021-05-13	（ｒ）−ジミラセタム（１）と（ｓ）−ジミラセタム（２）を非ラセミ比で含む相乗的組成物
CN104860847B (zh)	2017-06-27	利凡斯的明和咖啡酸、阿魏酸的二聚体,其制备方法及其药物组合物
EA012283B1 (ru)	2009-08-28	Новые соединения нафталина, способ их получения и фармацевтические композиции, содержащие их
Torregrosa et al.	2015	Chimeric derivatives of functionalized amino acids and α-aminoamides: Compounds with anticonvulsant activity in seizure models and inhibitory actions on central, peripheral, and cardiac isoforms of voltage-gated sodium channels
RU2010120847A (ru)	2011-11-27	Соединения индолина, фармацевтическая композиция на их основе и способ лечения или профилактики мелатонинергических заболеваний
HRP20180019T1 (hr)	2018-02-09	Stabilizirani amorfni oblik agomelatina, postupak za njegovu pripremu i farmaceutski pripravci koji ga sadržavaju
RU2012101227A (ru)	2013-07-27	1-(2-алкил-2,3-дигидро-бензофуран-4-ил)-пирролидин-3-иламинацильные соединения, фармацевтическая композиция и лекарственное средство на их основе и способ лечения или предупреждения мелатонергетических нарушений с их помощью
AR070003A1 (es)	2010-03-10	Derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
AR069004A1 (es)	2009-12-23	Compuestos de 2,3-dihidro-benzofurano sus usos para la preparacion de medicamentos y sus usos para el tratamiento de alteraciones melatoninergicas, y composiciones farmaceuticas que los comprende
RU2479572C2 (ru)	2013-04-20	Получение и применение производных фенилциклобутиламида и их стереоизомеров